1628 related articles for article (PubMed ID: 32496587)
21. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma.
Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J
Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
Liu A; Zhang X; Li R; Zheng M; Yang S; Dai L; Wu A; Hu C; Huang Y; Xie M; Chen Q
J Pathol; 2021 Jan; 253(1):17-30. PubMed ID: 32991738
[TBL] [Abstract][Full Text] [Related]
23. Tumor markers as an entry for SARS-CoV-2 infection?
Xia P; Dubrovska A
FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
[TBL] [Abstract][Full Text] [Related]
24. Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection.
Rajput SK; Logsdon DM; Kile B; Engelhorn HJ; Goheen B; Khan S; Swain J; McCormick S; Schoolcraft WB; Yuan Y; Krisher RL
F S Sci; 2021 Feb; 2(1):33-42. PubMed ID: 33521687
[TBL] [Abstract][Full Text] [Related]
25. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.
Raha AA; Chakraborty S; Henderson J; Mukaetova-Ladinska E; Zaman S; Trowsdale J; Raha-Chowdhury R
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33205807
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
27. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma.
Wark PAB; Pathinayake PS; Kaiko G; Nichol K; Ali A; Chen L; Sutanto EN; Garratt LW; Sohal SS; Lu W; Eapen MS; Oldmeadow C; Bartlett N; Reid A; Veerati P; Hsu AC; Looi K; Iosifidis T; Stick SM; Hansbro PM; Kicic A
Respirology; 2021 May; 26(5):442-451. PubMed ID: 33455043
[TBL] [Abstract][Full Text] [Related]
28. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G
J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427
[TBL] [Abstract][Full Text] [Related]
29. Ocular Surface Expression of SARS-CoV-2 Receptors.
Leonardi A; Rosani U; Brun P
Ocul Immunol Inflamm; 2020 Jul; 28(5):735-738. PubMed ID: 32589459
[TBL] [Abstract][Full Text] [Related]
30. Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
Coden ME; Loffredo LF; Abdala-Valencia H; Berdnikovs S
Viruses; 2021 Jun; 13(6):. PubMed ID: 34198852
[TBL] [Abstract][Full Text] [Related]
31. Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
Kermani NZ; Song WJ; Badi Y; Versi A; Guo Y; Sun K; Bhavsar P; Howarth P; Dahlen SE; Sterk PJ; Djukanovic R; Adcock IM; Chung KF;
Respir Res; 2021 Jan; 22(1):10. PubMed ID: 33413387
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility.
Daniel G; Paola AR; Nancy G; Fernando SO; Beatriz A; Zulema R; Julieth A; Claudia C; Adriana R
Infect Genet Evol; 2022 Oct; 104():105357. PubMed ID: 36038007
[TBL] [Abstract][Full Text] [Related]
33. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.
Qiao J; Li W; Bao J; Peng Q; Wen D; Wang J; Sun B
Biochem Biophys Res Commun; 2020 Dec; 533(4):867-871. PubMed ID: 33008593
[TBL] [Abstract][Full Text] [Related]
34. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
35. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
[TBL] [Abstract][Full Text] [Related]
36. Gene expression and
Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
[TBL] [Abstract][Full Text] [Related]
37. Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.
Adimulam T; Arumugam T; Gokul A; Ramsuran V
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240057
[TBL] [Abstract][Full Text] [Related]
38. Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.
Latini A; Vancheri C; Amati F; Morini E; Grelli S; Matteucci C; Petrone V; Colona VL; Murdocca M; Andreoni M; Malagnino V; Raponi M; Cocciadiferro D; Novelli A; Borgiani P; Novelli G
J Cell Mol Med; 2022 Oct; 26(19):4940-4948. PubMed ID: 36073344
[TBL] [Abstract][Full Text] [Related]
39. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
Hashemi SMA; Thijssen M; Hosseini SY; Tabarraei A; Pourkarim MR; Sarvari J
Arch Virol; 2021 Aug; 166(8):2089-2108. PubMed ID: 33934196
[TBL] [Abstract][Full Text] [Related]
40. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
Zarubin A; Stepanov V; Markov A; Kolesnikov N; Marusin A; Khitrinskaya I; Swarovskaya M; Litvinov S; Ekomasova N; Dzhaubermezov M; Maksimova N; Sukhomyasova A; Shtygasheva O; Khusnutdinova E; Radzhabov M; Kharkov V
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
